- The stock price of Olema Pharmaceuticals Inc (NASDAQ: OLMA) increased by 9.22% today. This is why.
The stock price of Olema Pharmaceuticals Inc (NASDAQ: OLMA) – a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers – increased by 9.22% today. Investors are responding positively to Olema Pharmaceuticals announcing that the company granted a stock option to one new employee to purchase 20,000 shares of the company’s common stock, effective as of April 1, 2022.
This award was approved by the Compensation Committee of Olema’s Board of Directors and granted under the company’s 2022 Inducement Plan, with a grant date of April 1, 2022, as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
The stock option vests over 4 years with 25% vesting on the first anniversary of the vesting commencement date for such employee and the remainder vesting in 36 equal monthly installments over the following three years, subject to the employee being continuously employed by Olema as of such vesting dates.
This stock option has a 10-year term and an exercise price of $4.10 per share, equal to the last reported sale price of the Company’s common stock as reported by Nasdaq on April 1, 2022. The stock option is subject to the terms of the Olema Pharmaceuticals, Inc. 2022 Inducement Plan.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.